bf/NASDAQ:INZY_icon.jpeg

COM:INOZYME

Inozyme

  • Stock

USD

Last Close

4.00

30/06 22:06

Market Cap

285.77M

Beta: -

Volume Today

462.93K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-6.96M
-
-19.72M
183.23%
-56.42M
186.07%
-56.62M
0.35%
-67.06M
18.43%
-71.17M
6.13%
depreciation and amortization
26K
-
83K
219.23%
217K
161.45%
674K
210.60%
744K
10.39%
1.29M
73.92%
deferred income tax
170K
-
1.38M
-
stock based compensation
444K
-
301K
32.21%
2.31M
666.78%
7.16M
210.40%
7.67M
7.09%
7.04M
8.28%
change in working capital
1.43M
-
601K
58.00%
-111K
118.47%
85K
176.58%
2.01M
2,267.06%
-3.08M
253.18%
accounts receivables
inventory
accounts payables
802K
-
-83K
110.35%
2.10M
2,627.71%
-675K
132.17%
150K
122.22%
-1.38M
1,018.67%
other working capital
629K
-
684K
8.74%
-2.21M
422.95%
760K
134.40%
1.86M
145%
-1.70M
191.51%
other non cash items
-4.37M
-
-71K
98.38%
18.04M
25,502.82%
378K
97.90%
-1.13M
398.41%
-6.13M
443.71%
net cash provided by operating activities
-9.44M
-
-18.81M
99.32%
-35.97M
91.25%
-48.15M
33.86%
-57.76M
19.95%
-70.67M
22.36%
investments in property plant and equipment
-259K
-
-139K
46.33%
-568K
308.63%
-397K
30.11%
-410K
3.27%
-298K
27.32%
acquisitions net
8.25K
-
116.61K
1,313.12%
-43.19K
137.04%
4.99K
111.56%
purchases of investments
-13.57M
-
-24.66M
81.77%
-177.92M
621.44%
-121.97M
31.45%
-151.99M
24.62%
-269.33M
77.20%
sales maturities of investments
22.83M
-
16.41M
28.13%
61.31M
273.62%
165.16M
169.38%
147M
11.00%
215.98M
46.93%
other investing activites
-8.25K
-
-116.61K
1,313.12%
43.19K
137.04%
-4.99K
111.56%
net cash used for investing activites
9.01M
-
-8.39M
193.17%
-117.18M
1,296.48%
42.80M
136.52%
-5.40M
112.63%
-53.65M
892.89%
debt repayment
-4.05M
-
-40M
887.65%
common stock issued
22.97M
-
115.97M
404.88%
609K
99.47%
56.14M
9,117.90%
85.97M
53.14%
common stock repurchased
92K
-
206K
123.91%
dividends paid
-4.05M
-
-40.32M
895.60%
other financing activites
31.95M
-
22.97K
99.93%
33.84M
147,222.59%
24.66M
-
120.12M
387.11%
net cash used provided by financing activities
31.95M
-
22.97M
28.10%
149.81M
552.21%
609K
99.59%
72.79M
11,852.05%
125.97M
73.06%
effect of forex changes on cash
24K
-
-25K
204.17%
-18K
28.00%
net change in cash
31.51M
-
-4.23M
113.43%
-3.34M
21.04%
-4.72M
41.39%
9.60M
303.20%
1.67M
82.57%
cash at beginning of period
4.45M
-
35.97M
707.86%
31.73M
11.76%
28.39M
10.53%
23.67M
16.64%
32.91M
39.06%
cash at end of period
35.97M
-
31.73M
11.76%
28.39M
10.53%
23.67M
16.64%
33.27M
40.55%
34.59M
3.96%
operating cash flow
-9.44M
-
-18.81M
99.32%
-35.97M
91.25%
-48.15M
33.86%
-57.76M
19.95%
-70.67M
22.36%
capital expenditure
-259K
-
-139K
46.33%
-568K
308.63%
-397K
30.11%
-410K
3.27%
-298K
27.32%
free cash flow
-9.70M
-
-18.95M
95.43%
-36.54M
92.84%
-48.55M
32.86%
-58.17M
19.82%
-70.97M
22.01%

All numbers in USD (except ratios and percentages)